Towards a urine test for the early diagnosis of ovarian cancer - Focus Tumor news. Previous research has shown that there are thousands of small molecules, called peptides, in the urine of women with ovarian cancer.
Experts have been looking for a new approach to more easily detect those peptides in urine in a low-cost way. The team used nanopore technology, which has the potential to simultaneously detect multiple peptides. According to the researchers, the system developed in this study points towards the possibility of developing a simple test.